Company
Alcresta Therapeutics
Enzyme products designed for enteral nutrition
Also known as alcresta, ALCRESTA THERAPEUTICS, INC.
- Headquarters
- Massachusetts, United States
- Customers
- patients who are enterally fed at home or in the hospital
- Legal name
- ALCRESTA THERAPEUTICS, INC.
- alcresta.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Alcresta develops rare disease, enzyme-based products helping to address fat malabsorption (often due to exocrine pancreatic insufficiency) in patients who are enterally fed at home or in the hospital.
Funding snapshot
- Total raised
- $75.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10M2020-02-28
Funding rounds
- Round, 2020
- $10M2020-02-28, SEC form D sold, 17 investors
- Round, 2019
- $5M2019-01-14, SEC form D sold, 19 investors
- Round, 2017
- $10M2017-09-15, SEC form D sold, 13 investors
- Round, 2016
- $50.9M2016-03-22, SEC form D sold, 13 investors
Products
- Hardware
- RELiZORB
- Web
- RELiZORB
- Web
- RELiZORBneo
Loading relationship preview